Balyasny Asset Management LLC Novo Nordisk A S Transaction History

Balyasny Asset Management LLC

$57.8 Billion
Q1 2025

A detailed history of Balyasny Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Balyasny Asset Management LLC holds 24,900 shares of NVO stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,900

Previous 2,800 789.29%

Holding current value

$1.65 Million

Previous $240,000 620.42%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$69.3 - $90.95 $29.1 Million - $38.2 Million	-420,105 Reduced 57.75%	307,409 $21.3 Million
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $17.2 Million - $24.3 Million	202,223 Added 38.5%	727,514 $62.6 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $16.9 Million - $20.6 Million	141,647 Added 36.92%	525,291 $62.5 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $47.1 Million - $56.4 Million	383,644 New	383,644 $54.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $35.4 Million - $42.6 Million	403,673 New	403,673 $41.8 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $13.8 Million - $16.6 Million	104,549 New	104,549 $16.6 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $15.8 Million - $19.9 Million	-187,096 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $12.7 Million - $15.9 Million	187,096 New	187,096 $15.7 Million
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $23.1 Million - $25.5 Million	-362,808 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $6.11 Million - $7.09 Million	-104,420 Reduced 22.35%	362,808 $23.8 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $11.4 Million - $14.9 Million	-229,764 Reduced 32.97%	467,228 $28.1 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $11.9 Million - $13.9 Million	-237,868 Reduced 25.44%	696,992 $40.3 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $31.2 Million - $35.1 Million	656,983 Added 236.43%	934,860 $48.3 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $6.76 Million - $7.58 Million	144,540 Added 108.4%	277,877 $14.2 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $5.95 Million - $6.75 Million	-128,263 Reduced 49.03%	133,337 $6.98 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $1.11 Million - $1.26 Million	-26,642 Reduced 9.24%	261,600 $12.1 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $4.63 Million - $5.08 Million	-99,106 Reduced 25.59%	288,242 $13.6 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $4.01 Million - $4.57 Million	90,568 Added 30.52%	387,348 $17.9 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $14.4 Million - $17.3 Million	296,780 New	296,780 $14.6 Million

Others Institutions Holding NVO

# of Institutions

1,763

Shares Held

328M

Call Options Held

10.8M

Put Options Held

14.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $149B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Novo Nordisk A S Transaction History